3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Burkitt Lymphoma
19
Lymphoma, Large B-Cell, Diffuse
15
Multiple Myeloma
14
Lymphoma, Non-Hodgkin
12
Lymphoma, Follicular
11
Lymphoma
11
Leukemia, Myeloid, Acute
11
Recurrence
10
Ovarian Neoplasms
8
Myelodysplastic Syndromes
8
Lymphoma, B-Cell
8
Pancreatic Neoplasms
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Leukemia
7
Lymphoma, Mantle-Cell
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Hodgkin Disease
6
Hematologic Neoplasms
6
Breast Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Leukemia, Myelomonocytic, Chronic
5
Triple Negative Breast Neoplasms
4
Stomach Neoplasms
4
Sarcoma
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Osteosarcoma
4
Lymphoma, Large-Cell, Anaplastic
4
Lymphoma, B-Cell, Marginal Zone
4
Interventions
pembrolizumab
6
Nivolumab
6
enfortumab vedotin
5
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Ipilimumab
4
sacituzumab govitecan
3
Docetaxel
3
CTLA-4 Antigen
3
cabozantinib
2
Taxes
2
Paclitaxel
2
Gemcitabine
2
relatlimab
1
eribulin
1
avelumab
1
atezolizumab
1
Single Person
1
Radiosurgery
1
Platinum
1
Cisplatin
1
Carboplatin
1
Axitinib
1
Antineoplastic Protocols
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Cyclophosphamide
×
30 days
×
Clear all
No trials found.